There are a couple of parts to this answer. We have significant capacity in Canada to manufacture vaccines. There was a bit of a misunderstanding early on. We did not have the capacity to manufacture mRNA vaccines. Those were the first ones that came out, and that's a new technology. We did not have the capacity to manufacture those particular types of vaccines. The GSK plant in Quebec City and the Sanofi plant in Toronto both use traditional protein-based vaccines. You can't interchange them. They're two completely different technologies.
The Medicago facility in Quebec City uses a plant-based technology for vaccines. They're in phase two clinical trials right now. It looks very promising. They released their data earlier this week. It looks very good that they will have a COVID-19 vaccine probably later this summer or early fall, which is very encouraging news. They have a significant facility that the Government of Quebec and the federal government have invested in. That will be coming online as well this fall.
We still need to develop more. There will be COVID-32 and COVID-40 or whatever it is, and we have to prepare for that. I think what we need to do now is figure out where we need to fill gaps in the biomanufacturing capacity and look at different ways to do that so that we are ready for the next one.